Страна: Австралия
Език: английски
Източник: Department of Health (Therapeutic Goods Administration)
Tobramycin sulfate
Phebra Pty Ltd
Medicine Listed (Export Only)
Tobra-day® Page 1 of 3 _Version 07 _ TOBRA-DAY ® CONTAINS 500 MG IN 5 ML TOBRAMYCIN (AS SULFATE) _toe-bruh-MY-sin _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Tobra-day. It does not contain all the available information. It does not take the place of talking to your doctor. All medicines have risks and benefits . Your doctor has weighed the risks of you being given Tobra-day against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR. KEEP THIS LEAFLET IN A SAFE PLACE. You may need to read it again. WHAT TOBRA-DAY IS USED FOR Tobra-day is an antibiotic used to treat serious lung infections caused by bacteria in patients with cystic fibrosis. This medicine belongs to a group of medicines called aminoglycosides. It works by killing the bacteria causing the infection. DO NOT GIVE THIS MEDICINE TO CHILDREN UNDER 5 YEARS OF AGE. There is not enough information to recommend the use of this medicine for children under the age of 5 years. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is available only with a doctor’s prescription._ _ BEFORE YOU ARE GIVEN TOBRA-DAY _WHEN YOU MUST NOT BE GIVEN _ _THE MEDICINE_ _ _ YOU SHOULD NOT BE GIVEN TOBRA-DAY IF YOU HAVE AN ALLERGY TO: • any medicine containing tobramycin or tobramycin sulfate • any of the ingredients listed at the end of this leaflet • any other aminoglycoside antibiotic such as streptomycin, gentamicin, amikacin, kanamycin, netilmicin or neomyc Прочетете целия документ
_PRODUCT INFORMATION _ ___________________________________________________________________________________________________ Product Information Tobra-day® Page 1 of 8 Version 12 _ _ Tobra-day ® TOBRAMYCIN (AS SULFATE) 500 MG IN 5 ML INJECTION NAME OF THE MEDICINE Tobramycin 4-O-(3-Amino-3-deoxy-α-d-glucopyranosyl)-2-deoxy-6-O-(2,6-diamino-2,3,6-trideoxy-α-d-ribo-hexopyranosyl)-l-streptamine. The molecular weight of the compound is 467.5 and the CAS registry number is 32986-56-4. The molecular formula is C 18 H 37 N 5 O 9 Structural Formula: DESCRIPTION Tobra-day is a sterile, clear, straw to pale yellow coloured solution containing tobramycin sulfate equivalent to 100 mg/mL tobramycin base in water for injections. Sulfuric acid and sodium hydroxide may be added to adjust pH (3.5-6.0). The solution is preservative free. Tobramycin sulfate is a water soluble antibiotic of the aminoglycoside group and is produced by Streptomyces tenebrarius. PHARMACOLOGY Pharmacokinetics Absorption Tobramycin is rapidly absorbed following intramuscular injection and peak serum concentrations occur between 30 and 90 minutes after injection. In adults with normal renal function a single intramuscular injection of 1 mg/kg body weight will produce maximum serum levels of approximately 4 micrograms/mL and are measurable for as long as eight hours. When tobramycin is administered by the intravenous route over a period of one hour serum concentrations are similar to those obtained after intramuscular injection. Tobramycin is poorly absorbed from the gastrointestinal tract. Distribution After parenteral administratio Прочетете целия документ